SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-21-111080
Filing Date
2021-08-30
Accepted
2021-08-30 16:52:20
Documents
7
Effectiveness Date
2021-08-30

Document Format Files

Seq Description Document Type Size
1 FORM S-8 tm2126055d1_s8.htm S-8 94076
2 EXHIBIT 5.1 tm2126055d1_ex5-1.htm EX-5.1 8717
3 EXHIBIT 23.1 tm2126055d1_ex23-1.htm EX-23.1 3147
4 EXHIBIT 23.2 tm2126055d1_ex23-2.htm EX-23.2 2644
5 GRAPHIC tm2126055d1_ex5-1img001.jpg GRAPHIC 4166
6 GRAPHIC tm2126055d1_ex23-1img001.jpg GRAPHIC 3723
7 GRAPHIC tm2126055d1_ex23-1img002.jpg GRAPHIC 3615
  Complete submission text file 0001104659-21-111080.txt   125979
Mailing Address 4850 WEST 78TH STREET INDIANAPOLIS IN 46268
Business Address 4850 WEST 78TH STREET INDIANAPOLIS IN 46268 (647) 401-2182
POINT Biopharma Global Inc. (Filer) CIK: 0001811764 (see all company filings)

IRS No.: 850800493 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-259171 | Film No.: 211224179
SIC: 2834 Pharmaceutical Preparations